Grants and Contributions:
Title:
Clinical Study of Safety and Immunogenicity of Nasal Poly-ICLC (Hiltonol®) for Prophylaxis of COVID-19 in Healthy Adults
Agreement Number:
RD-003
Agreement Value:
$2,099,792.00
Agreement Date:
Mar 16, 2021 - Dec 29, 2023
Description:
Develop immunoassay kits that can measure all three classes of SARS-CoV-2 antibodies simultaneously or individually.
Organization:
National Defence
Location:
Vancouver, British Columbia, CA
Reference Number:
018-2023-2024-Q1-RD-003
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Type:
For-profit organization
Amendment Date
Apr 14, 2023
Recipient's Legal Name:
Oncovir Canada Inc
Program:
Innovation for Defence Excellence and Security Program - Innovation Networks
Program Purpose:
Collaborate with academic and private sector partners to build a network of expertise to support Canada’s current and future defence and security needs.
Amendments: